Market revenue in 2023 | USD 1,242.7 million |
Market revenue in 2030 | USD 2,103.8 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Brazil formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil accounts for the largest biopharmaceutical sector share in the region and the country is also expected to dominate the LATAM drug formulation development outsourcing market during the forecast period.
Brazil is highly chosen to be the target country for international generic & innovator companies owing to its cost-effective drug manufacturing process and wide presence of outsourcing providers, thereby contributing to the growth of the market.
Moreover, the country has also grown exponentially in research & development and clinical trial activities over the last few years. Therefore, Brazil is considered to be one of the three fast growing countries in clinical research, following India and Russia.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account